Synchron

Synchron is a California-based biotechnology company that researches and develops implantable endovascular brain-computer interface devices for the healthcare industry.

Business Model:

Revenue: $70M

Employees: 51-200

Detailed Synchron Information

Geographic Data

Synchron headquarters map

Address: 1999 S Bascom Avenue

City: Campbell

State: CA

Zip: 95008

Country: US

Financial Info

Stage:

undisclosed

Raised Last:

$0

Raised Total:

$50M

Metrics

1,238,464Website Global Rank

24,086Website Monthly Traffic

Twitter Followers

Description

Synchron is a California-based biotechnology company that researches and develops implantable endovascular brain-computer interface devices for the healthcare industry.

Contact Phone:
+19172160774

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2020 Grant $990k MTPConnect
1/2005 Venture Round 1 $5M Sigma Partners
Sigma Partners
11/2022 Series C $75M ARCH Venture Partners
Bezos Expeditions
Greenoaks
Alumni Ventures
Moore Strategic Ventures
Project X
Khosla Ventures
Metis
Forepont Capital Partners
ID8 Investments
Shanda Group
University of Melbourne
12/2022 Series C 17 $75M University of Melbourne
Subversive Capital
Shanda Group
Reliance Industries
Project X
Neurotechnology Investors
Moore Strategic Ventures
METIS innovative
Khosla Ventures
ID8 Investments
University of Melbourne
Subversive Capital
Shanda Group
Reliance Industries
Project X
Neurotechnology Investors
Moore Strategic Ventures
METIS innovative
Khosla Ventures
ID8 Investments
12/2022 Series C 16 $75M University of Melbourne
Shanda Capital
Reliance Digital Health
Project X
Neurotechnology Investors
Moore Strategic Ventures
METIS innovative
Khosla Ventures
ID8 Investments
Greenoaks
University of Melbourne
Shanda Capital
Reliance Digital Health
Project X
Neurotechnology Investors
Moore Strategic Ventures
METIS innovative
Khosla Ventures
ID8 Investments
Greenoaks
2/2022 Venture Round 1 - Max Hodak
Max Hodak
6/2021 Series B $0 Khosla Ventures
Arani Bose
Forepont Capital Partners
Thomas Reardon
Subversive Capital
University of Melbourne
re.Mind Capital
General Advance
Shanda Group
Khosla Ventures
ID8 Investments
METIS innovative
Neurotechnology Investors
Khosla Ventures
Arani Bose
Forepont Capital Partners
Thomas Reardon
Subversive Capital
University of Melbourne
re.Mind Capital
General Advance
Shanda Group
Khosla Ventures
ID8 Investments
METIS innovative
Neurotechnology Investors
2/2022 Funding Round 1 - Max Hodak
Max Hodak
5/2021 Series B $40M Khosla Ventures
Forepont Capital Partners
ID8 Investments
Shanda Group
General Advance
Subversive Capital
re.Mind Capital
NeuroTechnology Investors
METIS innovative
University of Melbourne
4/2017 Series A 2 $10M Neurotechnology Investors
DARPA
Neurotechnology Investors
2/2022 Funding Round 1 - Max Hodak
Max Hodak
6/2021 Series B 12 $40M Khosla Ventures
Arani Bose
Forepont Capital Partners
Thomas Reardon
Subversive Capital
University of Melbourne
re.Mind Capital
General Advance
Shanda Group
Khosla Ventures
Khosla Ventures
Arani Bose
Forepont Capital Partners
Thomas Reardon
Subversive Capital
University of Melbourne
re.Mind Capital
General Advance
Shanda Group
Khosla Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research